Predicting patient-to-patient variability in proteolytic activity and breast cancer progression
About one in eight women in the United States will develop breast cancer over the course of her lifetime. Moreover, patient-to-patient variability in disease progression continues to complicate clinical decisions in diagnosis and treatment for breast cancer patients. Early detection of tumors is a k...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | en_US |
| Published: |
Georgia Institute of Technology
2015
|
| Subjects: | |
| Online Access: | http://hdl.handle.net/1853/53479 |